Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,664 | -17,315 | -9,697 | -13,160 | -7,219 |
| Depreciation Amortization | 157 | 45 | 8 | 760 | 756 |
| Accounts receivable | 78 | 21 | 16 | N/A | -80 |
| Other Working Capital | 3,102 | 704 | 1,236 | 1,920 | 2,021 |
| Other Operating Activity | 5,047 | 3,868 | 2,429 | -850 | -1,902 |
| Operating Cash Flow | $-18,280 | $-12,677 | $-6,008 | $-11,330 | $-6,424 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -208 | -171 | -142 | -10 | -6 |
| Purchase Of Investment | -64,497 | -24,291 | 0 | -13,396 | -13,154 |
| Sale Of Investment | 6,990 | 6,745 | 5,500 | 1,990 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -4 | 0 |
| Investing Cash Flow | $-57,715 | $-17,717 | $5,358 | $-11,420 | $-13,160 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3 | -2 | 0 | N/A | N/A |
| Common Stock Issued | 104,293 | 104,596 | 0 | 5 | N/A |
| Common Stock Repurchased | -79 | -21 | N/A | N/A | N/A |
| Other Financing Activity | 237 | 0 | 105,754 | 42,325 | 42,546 |
| Financing Cash Flow | $104,448 | $104,573 | $105,754 | $42,330 | $42,546 |
| Beginning Cash Position | 21,215 | 21,215 | 21,215 | 1,640 | 1,641 |
| End Cash Position | 49,668 | 95,394 | 126,319 | 21,210 | 24,603 |
| Net Cash Flow | $28,453 | $74,179 | $105,104 | $19,570 | $22,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,280 | -12,677 | -6,008 | -11,330 | -6,424 |
| Capital Expenditure | -208 | -171 | -142 | -19 | -6 |
| Free Cash Flow | -18,488 | -12,848 | -6,150 | -11,349 | -6,430 |